Techno Medica Co., Ltd. (TYO:6678)

Market Cap	14.84B +22.0%
Revenue (ttm)	10.70B +3.8%
Net Income	1.04B -8.0%
EPS	149.70 -8.1%
Shares Out	6.97M
PE Ratio	14.23
Forward PE	n/a
Dividend	68.00 (3.18%)
Ex-Dividend Date	Mar 30, 2026

Volume	10,200
Average Volume	7,120
Open	2,157.00
Previous Close	2,136.00
Day's Range	2,117.00 - 2,158.00
52-Week Range	1,783.00 - 2,787.00
Beta	0.29
RSI	33.60
Earnings Date	May 8, 2026

About Techno Medica

Techno Medica Co., Ltd. engages in the research and development, manufacture, sale, import, and export of in-vitro diagnostic analyzers in Japan. The company offers automated tube selecting and labeling systems, RFID process control system, blood and urine collection support, and pre-analytical instrument. It also provides consumables and after sales services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 244
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 6678

Financial Performance

In fiscal year 2025, Techno Medica's revenue was 9.91 billion, a decrease of -3.68% compared to the previous year's 10.28 billion. Earnings were 1.00 billion, a decrease of -25.52%.